PUMA BIOTECHNOLOGY, INC.
Balance Sheet
| Line Item | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $90.9M | $83.4M | $60.0M | $58.9M | $27.2M | $48.8M | $108.4M | $68.3M |
| Accounts Receivable | $24.0M | $31.5M | $28.9M | $27.2M | $25.3M | $81.0M | $20.8M | $19.8M |
| Inventory | $2.9M | $3.3M | $3.2M | $3.1M | $3.3M | $2.6M | $2.6M | $2.8M |
| Total Current Assets | $159.2M | $158.7M | $166.3M | $151.1M | $157.6M | $256.2M | $203.0M | $174.4M |
| Property, Plant & Equipment | $2.9M | $3.1M | $3.3M | $3.2M | $3.4M | $3.7M | $4.0M | $4.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $40.5M | — | — | — | $44.4M | — |
| Total Assets | $263.8M | $225.5M | $234.9M | $232.0M | $239.9M | $331.4M | $259.1M | $230.7M |
| Liabilities | ||||||||
| Accounts Payable | $11.8M | $17.3M | $19.2M | $9.1M | $15.1M | $28.9M | $20.7M | $16.4M |
| Total Current Liabilities | $94.5M | $90.5M | $90.8M | $88.3M | $91.7M | $101.4M | $67.1M | $57.9M |
| Long-Term Debt | $96.6M | $95.8M | $95.0M | $94.2M | $93.4M | $152.8M | $151.9M | $121.1M |
| Total Liabilities | $240.4M | $216.2M | $217.4M | $214.9M | $218.1M | $287.9M | $224.8M | $184.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.29B | $-1.29B | $-1.28B | $-1.27B | $-1.25B | $-1.21B | $-1.20B | $-1.17B |
| Total Stockholders' Equity | $23.4M | $9.4M | $17.5M | $17.2M | $21.8M | $43.5M | $34.3M | $45.9M |